Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of death in women worldwide, and its E7 antigen is the major candidate for a therapeutic vaccine. The large scale production of E7 by molecular farming that would lead to the development of a safe and inexpensive vaccine is impaired by its low accumulation level in the plant cell. To enhance antigen production in the plastids, two alternative strategies were carried out: the expression of E7 as a translational fusion to β-glucuronidase enzyme and redirection of E7 into the thylakoid lumen. The use of the β-glucuronidase as a partner protein turned out to be a successful strategy, antigen expression levels were enhanced between 30 to 40 times rel...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
The chloroplast genetic engineering offers a number of unique advantages including high level of tra...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Cervical cancer linked to infection with human papillomavirus (HPV) is the third cause of cancer-rel...
Durante este trabajo se obtuvieron distintas líneas de plantas de tabaco transplantómicas para el an...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular trans...
Orthopoxviruses (OPVs) have recently received increasing attention because of their potential use in...
Cervical cancer is the second most prevalent cancer in women worldwide. It is linked to infection wi...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Cervical cancer is the most common malignancy among women particularly in developing countries, with...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Um eine neue Plattform zur Impfstoff-Produktion für einkommensschwache Länder zu entwickeln, untersu...
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great ...
Introduction: Human papillomavirus (HPV) infection is the leading cause of cervical cancer, and vacc...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
The chloroplast genetic engineering offers a number of unique advantages including high level of tra...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Cervical cancer linked to infection with human papillomavirus (HPV) is the third cause of cancer-rel...
Durante este trabajo se obtuvieron distintas líneas de plantas de tabaco transplantómicas para el an...
Human Papillomavirus (HPV) is the causal agent of cervical cancer, one of the most common causes of ...
The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular trans...
Orthopoxviruses (OPVs) have recently received increasing attention because of their potential use in...
Cervical cancer is the second most prevalent cancer in women worldwide. It is linked to infection wi...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
Cervical cancer is the most common malignancy among women particularly in developing countries, with...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Um eine neue Plattform zur Impfstoff-Produktion für einkommensschwache Länder zu entwickeln, untersu...
Virus-like particle-based vaccines for high-risk human papillomaviruses (HPVs) appear to have great ...
Introduction: Human papillomavirus (HPV) infection is the leading cause of cervical cancer, and vacc...
Chloroplast genetic engineering offers several advantages, including high levels of transgene expres...
The chloroplast genetic engineering offers a number of unique advantages including high level of tra...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...